Open AccessMyeloperoxidase -463 G/A polymorphism is associated with lung cancer risk
Author(s) -
Shengqiang Zou,
Xin Pan,
Changsong Hua,
Min Wu,
Bin He,
Zhigang Chen
Publication year - 2018
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.235341
Subject(s) - lung cancer , odds ratio , medicine , confidence interval , subgroup analysis , gastroenterology , myeloperoxidase , meta analysis , lung cancer susceptibility , oncology , genotype , single nucleotide polymorphism , biology , genetics , inflammation , gene
Several studies evaluated the association between myeloperoxidase (MPO) -463 G/A polymorphism and the risk of lung cancer. However, the results were not stable.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom